BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34375173)

  • 1. Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer.
    Ozkan E; Bakar-Ates F
    Curr Med Chem; 2022; 29(1):41-55. PubMed ID: 34375173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
    Zhu L; Meng D; Wang X; Chen X
    ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
    Skoupilová H; Michalová E; Hrstka R
    Klin Onkol; 2018; 31(Suppl 2):21-26. PubMed ID: 31023020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities.
    Lei G; Gan B
    Cancer Res; 2024 Apr; 84(7):961-964. PubMed ID: 38558130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron based nanotherapeutics for ferroptosis-induced cancer therapy.
    Liu YM; Chen YH; Jin YC; Tang KZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11323-11333. PubMed ID: 33215452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.
    Zhang C; Liu X; Jin S; Chen Y; Guo R
    Mol Cancer; 2022 Feb; 21(1):47. PubMed ID: 35151318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadening horizons: the role of ferroptosis in cancer.
    Chen X; Kang R; Kroemer G; Tang D
    Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in cancer stem cells.
    Xu T; Liu Y; Zhao Z; Liu J; Chai J; Yang Y; Zuo S; Li M; Jia Q
    Pathol Res Pract; 2023 May; 245():154492. PubMed ID: 37119732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives.
    Yadav M; Niveria K; Sen T; Roy I; Verma AK
    Nanomedicine (Lond); 2021 May; 16(12):1049-1065. PubMed ID: 33970686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.
    Yao Y; Shi Y; Gao Z; Sun Y; Yao F; Ma L
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C95-C103. PubMed ID: 35613358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis inducers: A new frontier in cancer therapy.
    Ma W; Hu N; Xu W; Zhao L; Tian C; Kamei KI
    Bioorg Chem; 2024 May; 146():107331. PubMed ID: 38579614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erastin‑induced ferroptosis causes physiological and pathological changes in healthy tissues of mice.
    Zhao J; Xu B; Xiong Q; Feng Y; Du H
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities for Ferroptosis in Cancer Therapy.
    Fujihara KM; Zhang BZ; Clemons NJ
    Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34205617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
    Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
    Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
    Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells.
    Pandrangi SL; Chittineedi P; Chalumuri SS; Meena AS; Neira Mosquera JA; Sánchez Llaguno SN; Pamuru RR; Mohiddin GJ; Mohammad A
    Molecules; 2022 May; 27(9):. PubMed ID: 35566360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.